Log in
NASDAQ:BLCM

Bellicum Pharmaceuticals News Headlines

$3.09
+0.03 (+0.98 %)
(As of 12/4/2020 12:00 AM ET)
Add
Compare
Today's Range
$3.04
Now: $3.09
$3.12
50-Day Range
$2.80
MA: $4.07
$6.87
52-Week Range
$2.74
Now: $3.09
$27.90
Volume291,941 shs
Average Volume140,312 shs
Market Capitalization$15.64 million
P/E RatioN/A
Dividend YieldN/A
Beta2.08

Headlines

Bellicum Pharmaceuticals (NASDAQ BLCM) News Headlines Today

Source:
SourceHeadline
Bellicum Pharmaceuticals (NASDAQ:BLCM)  Shares Down 12.5% Bellicum Pharmaceuticals (NASDAQ:BLCM) Shares Down 12.5%
americanbankingnews.com - December 1 at 9:08 PM
Bellicum Pharmaceuticals (NASDAQ:BLCM) Stock Price Up 15.7%Bellicum Pharmaceuticals (NASDAQ:BLCM) Stock Price Up 15.7%
americanbankingnews.com - November 30 at 6:56 PM
Is Bellicum Pharmaceuticals Inc (BLCM) A Good Stock To Buy?Is Bellicum Pharmaceuticals Inc (BLCM) A Good Stock To Buy?
finance.yahoo.com - November 27 at 8:52 PM
Bellicum Pharmaceuticals (NASDAQ:BLCM) Trading 5.6% Higher Bellicum Pharmaceuticals (NASDAQ:BLCM) Trading 5.6% Higher
americanbankingnews.com - November 20 at 7:14 PM
Bellicum Pharmaceuticals (BLCM) Upgraded to Buy: Heres What You Should KnowBellicum Pharmaceuticals (BLCM) Upgraded to Buy: Here's What You Should Know
finance.yahoo.com - November 20 at 1:13 PM
 Brokerages Anticipate Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) Will Announce Earnings of -$1.05 Per Share Brokerages Anticipate Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) Will Announce Earnings of -$1.05 Per Share
americanbankingnews.com - November 15 at 5:41 PM
Bellicum Pharmaceuticals (NASDAQ:BLCM) Stock Price Up 8.7%Bellicum Pharmaceuticals (NASDAQ:BLCM) Stock Price Up 8.7%
americanbankingnews.com - November 11 at 7:21 PM
Bellicum Reports Third Quarter 2020 Financial Results and Provides Operational UpdateBellicum Reports Third Quarter 2020 Financial Results and Provides Operational Update
finance.yahoo.com - November 5 at 7:55 PM
Bellicum Pharmaceuticals Announces Closing of $25.0 Million Underwritten OfferingBellicum Pharmaceuticals Announces Closing of $25.0 Million Underwritten Offering
finance.yahoo.com - November 3 at 11:44 PM
BUZZ-U.S. STOCKS ON THE MOVE-BioLine RX Ltd, Bellicum Pharma, MoneyGramBUZZ-U.S. STOCKS ON THE MOVE-BioLine RX Ltd, Bellicum Pharma, MoneyGram
nasdaq.com - November 1 at 8:23 PM
BUZZ-U.S. STOCKS ON THE MOVE-BioLine RX, Bellicum Pharma, Mohawk IndustriesBUZZ-U.S. STOCKS ON THE MOVE-BioLine RX, Bellicum Pharma, Mohawk Industries
nasdaq.com - October 30 at 11:25 AM
Bellicum Pharma slashes headcount by 79%Bellicum Pharma slashes headcount by 79%
seekingalpha.com - October 29 at 10:43 PM
Bellicum launches $25M underwritten offeringBellicum launches $25M underwritten offering
seekingalpha.com - October 29 at 10:43 PM
Bellicum Announces Interim BPX-601 Data and Corporate RestructuringBellicum Announces Interim BPX-601 Data and Corporate Restructuring
finance.yahoo.com - October 29 at 5:39 PM
Bellicum Announces $25.0 Million Underwritten Offering Priced At-The-MarketBellicum Announces $25.0 Million Underwritten Offering Priced At-The-Market
finance.yahoo.com - October 29 at 5:39 PM
Wells Fargo: These 2 Stocks Could Deliver Triple-Digit WinsWells Fargo: These 2 Stocks Could Deliver Triple-Digit Wins
finance.yahoo.com - September 18 at 1:10 PM
Stock Alert: Bellicum Pharmaceuticals Soars 25%Stock Alert: Bellicum Pharmaceuticals Soars 25%
nasdaq.com - September 15 at 1:11 PM
Bellicum Pharmaceuticals, Inc. (BLCM) CEO Richard Fair on Q2 2020 Results - Earnings Call TranscriptBellicum Pharmaceuticals, Inc. (BLCM) CEO Richard Fair on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 7 at 12:40 AM
Bellicum Reports Second Quarter 2020 Financial Results and Provides Operational UpdateBellicum Reports Second Quarter 2020 Financial Results and Provides Operational Update
finance.yahoo.com - August 6 at 7:39 PM
Bellicum to Report Second Quarter 2020 Financial Results and Provide Corporate UpdateBellicum to Report Second Quarter 2020 Financial Results and Provide Corporate Update
finance.yahoo.com - July 30 at 5:18 PM
Bellicum Pharma on go with mid-stage study of BPX-603 for HER2+ solid tumorsBellicum Pharma on go with mid-stage study of BPX-603 for HER2+ solid tumors
seekingalpha.com - June 15 at 9:12 AM
Bellicum Receives FDA IND Clearance to Initiate a Phase 1/2 Clinical Trial for BPX-603, a Dual-Switch GoCAR-T® for HER2+ Solid TumorsBellicum Receives FDA IND Clearance to Initiate a Phase 1/2 Clinical Trial for BPX-603, a Dual-Switch GoCAR-T® for HER2+ Solid Tumors
finance.yahoo.com - June 15 at 9:12 AM
Here is What Hedge Funds Think About Bellicum Pharmaceuticals Inc (BLCM)Here is What Hedge Funds Think About Bellicum Pharmaceuticals Inc (BLCM)
finance.yahoo.com - June 12 at 1:49 PM
Top Ranked Momentum Stocks to Buy for June 1stTop Ranked Momentum Stocks to Buy for June 1st
finance.yahoo.com - June 1 at 1:45 PM
Bellicum Announces Publication of Data for GoCAR-NK™ Cell ProgramBellicum Announces Publication of Data for GoCAR-NK™ Cell Program
finance.yahoo.com - May 27 at 5:47 PM
Bellicum to Participate in Two Upcoming Virtual Investor ConferencesBellicum to Participate in Two Upcoming Virtual Investor Conferences
finance.yahoo.com - May 27 at 7:47 AM
All You Need to Know About Bellicum Pharmaceuticals (BLCM) Rating Upgrade to Strong BuyAll You Need to Know About Bellicum Pharmaceuticals (BLCM) Rating Upgrade to Strong Buy
finance.yahoo.com - May 22 at 3:01 PM
Bellicum Reports First Quarter 2020 Financial Results and Provides Operational Update  Bellicum Reports First Quarter 2020 Financial Results and Provides Operational Update  
finance.yahoo.com - May 7 at 4:39 PM
The Bellicum Pharmaceuticals (NASDAQ:BLCM) Share Price Is Down 98% So Some Shareholders Are Very SaltyThe Bellicum Pharmaceuticals (NASDAQ:BLCM) Share Price Is Down 98% So Some Shareholders Are Very Salty
finance.yahoo.com - May 6 at 2:59 PM
Houston pharma co. completes $15M facility sale to M.D. Anderson as drug research stallsHouston pharma co. completes $15M facility sale to M.D. Anderson as drug research stalls
finance.yahoo.com - April 17 at 7:47 PM
Bellicum Completes Sale of Houston FacilityBellicum Completes Sale of Houston Facility
finance.yahoo.com - April 15 at 9:16 AM
Edited Transcript of BLCM earnings conference call or presentation 12-Mar-20 9:00pm GMTEdited Transcript of BLCM earnings conference call or presentation 12-Mar-20 9:00pm GMT
finance.yahoo.com - March 29 at 4:51 PM
88 Stocks Moving In Fridays Mid-Day Session88 Stocks Moving In Friday's Mid-Day Session
www.msn.com - March 14 at 12:09 AM
Bellicum Pharmaceuticals, Inc. (BLCM) CEO Richard Fair on Q4 2019 Results - Earnings Call TranscriptBellicum Pharmaceuticals, Inc. (BLCM) CEO Richard Fair on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - March 12 at 11:39 PM
Bellicum Pharmaceuticals EPS misses by $1.49Bellicum Pharmaceuticals EPS misses by $1.49
seekingalpha.com - March 12 at 6:39 PM
Bellicum Pharmaceuticals, Inc. to Host Earnings CallBellicum Pharmaceuticals, Inc. to Host Earnings Call
finance.yahoo.com - March 12 at 6:39 PM
Startek, Inc. to Host Earnings CallStartek, Inc. to Host Earnings Call
finance.yahoo.com - March 12 at 6:39 PM
Bellicum Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Operational UpdateBellicum Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Operational Update
finance.yahoo.com - March 12 at 6:39 PM
Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) Insiders Increased Their HoldingsBellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) Insiders Increased Their Holdings
finance.yahoo.com - March 10 at 8:29 AM
Bellicum to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate UpdateBellicum to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update
finance.yahoo.com - March 5 at 11:12 AM
Bellicum Pharmaceuticals (BLCM) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseBellicum Pharmaceuticals (BLCM) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
finance.yahoo.com - March 3 at 2:23 PM
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - February 28 at 6:05 PM
Bellicum Pharmaceuticals, Inc. Common Stock (BLCM) Insider ActivityBellicum Pharmaceuticals, Inc. Common Stock (BLCM) Insider Activity
www.nasdaq.com - February 28 at 8:04 AM
Houston biotech firm raises millions; pharma co. enacts reverse stock splitHouston biotech firm raises millions; pharma co. enacts reverse stock split
finance.yahoo.com - February 7 at 12:28 PM
Bellicum Announces Reverse Stock SplitBellicum Announces Reverse Stock Split
finance.yahoo.com - February 5 at 12:51 PM
Bellicum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Bellicum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - January 31 at 5:01 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Bellicum Pharmaceuticals, Inc.- BLCMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Bellicum Pharmaceuticals, Inc.- BLCM
finance.yahoo.com - January 31 at 12:00 PM
Heres What We Think About Bellicum Pharmaceuticals, Inc.s (NASDAQ:BLCM) CEO PayHere's What We Think About Bellicum Pharmaceuticals, Inc.'s (NASDAQ:BLCM) CEO Pay
finance.yahoo.com - January 25 at 3:54 PM
Here's What We Think About Bellicum Pharmaceuticals, Inc.'s (NASDAQ:BLCM) CEO PayHere's What We Think About Bellicum Pharmaceuticals, Inc.'s (NASDAQ:BLCM) CEO Pay
finance.yahoo.com - January 25 at 9:49 AM
Bellicum up 9% premarket on BPX-601 dataBellicum up 9% premarket on BPX-601 data
seekingalpha.com - January 24 at 1:44 PM
This page was last updated on 12/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.